| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459565 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
Pretreatment ADC value derived from high b-values is an independent prognostic factor in HNSCC and increases the performance of a multivariable prognostic model in addition to known clinical and radiological variables. Integration of other biomarkers and external validation is necessary to ensure its clinical applicability.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Maarten Lambrecht, Ben Van Calster, Vincent Vandecaveye, Frederik De Keyzer, Ilse Roebben, Robert Hermans, Sandra Nuyts,